JP Stock MarketDetailed Quotes

COSMOS Pharmaceutical (3349)

Watchlist
  • 6048.0
  • -131.0-2.12%
20min DelayMarket Closed May 22 15:30 JST
483.85BMarket Cap15.47P/E (Static)

COSMOS Pharmaceutical (3349) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Feb 28, 2026
(Q1)Aug 31, 2025
(FY)May 31, 2025
(Q1)Aug 31, 2024
(FY)May 31, 2024
(Q4)May 31, 2024
(Q3)Feb 29, 2024
(Q2)Nov 30, 2023
(Q1)Aug 31, 2023
(FY)May 31, 2023
Total revenue
273.21B
4.03%272.39B
4.81%1.01T
8.35%261.84B
16.59%964.99B
249.68B
18.09%238.88B
18.64%234.78B
17.24%241.65B
9.57%827.7B
Cost of revenue
216.15B
3.83%215.22B
2.76%798.11B
6.49%207.28B
17.86%776.68B
201.04B
19.21%192.15B
20.31%188.86B
18.81%194.64B
9.11%658.98B
Gross profit
57.06B
4.79%57.17B
13.26%213.28B
16.06%54.56B
11.61%188.31B
48.64B
13.72%46.73B
12.21%45.92B
11.16%47.01B
11.40%168.72B
Operating expense
45.71B
5.93%45.53B
10.25%172.88B
13.05%42.98B
13.14%156.8B
40.88B
13.16%38.83B
13.47%39.07B
13.86%38.02B
13.92%138.59B
Operating profit
11.35B
0.56%11.65B
28.26%40.4B
28.80%11.58B
4.55%31.5B
7.76B
16.53%7.9B
5.55%6.85B
1.02%8.99B
1.12%30.13B
Net non-operating interest income (expenses)
-91M
-118.42%-83M
-274.55%-206M
-375.00%-38M
-1,275.00%-55M
-35M
-700.00%-6M
-700.00%-6M
-700.00%-8M
-4M
Non-operating interest income
--16M
145.45%27M
9.09%48M
10.00%11M
-6.38%44M
--11M
0.00%12M
-8.33%11M
-9.09%10M
-9.62%47M
Non-operating interest expense
--107M
124.49%110M
156.57%254M
172.22%49M
94.12%99M
--46M
63.64%18M
54.55%17M
50.00%18M
-1.92%51M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
28M
56.00%-99M
-35.75%-786M
-268.85%-225M
-86.17%-579M
-609M
723.08%162M
21.11%-71M
-41.86%-61M
-266.31%-311M
Less:Restructuring and mergern&acquisition
---15M
--0
-55.07%31M
-25.93%20M
-63.49%69M
--51M
-311.11%-19M
-58.33%10M
80.00%27M
20.38%189M
Less:Other special charges
---13M
-51.71%99M
3,120.00%755M
502.94%205M
-120.49%-25M
--23M
-941.18%-143M
-7.58%61M
21.43%34M
135.47%122M
Less:Write off
----
----
----
----
--535M
----
----
----
----
--0
Other non-operating income (expenses)
676M
-16.78%625M
3.75%2.96B
5.03%751M
-3.61%2.85B
659M
-5.35%672M
2.28%807M
-1.52%715M
-3.46%2.96B
Income before tax
11.96B
0.18%12.09B
25.66%42.37B
25.22%12.07B
2.89%33.72B
7.78B
16.89%8.73B
5.49%7.58B
0.57%9.64B
-0.83%32.77B
Income tax
3.86B
-0.15%3.92B
22.97%11.39B
25.38%3.92B
3.23%9.27B
681M
19.17%2.96B
5.54%2.5B
0.94%3.13B
-9.27%8.98B
Net income
8.1B
0.34%8.17B
26.68%30.98B
25.12%8.14B
2.76%24.45B
7.1B
15.77%5.77B
5.42%5.08B
0.42%6.51B
2.77%23.8B
Net income continuous operations
--8.1B
0.34%8.17B
26.68%30.98B
25.14%8.14B
2.76%24.45B
--7.1B
15.75%5.77B
5.46%5.08B
0.40%6.51B
2.77%23.8B
Noncontrolling interests
Net income attributable to the company
8.1B
0.34%8.17B
26.68%30.98B
25.12%8.14B
2.76%24.45B
7.1B
15.77%5.77B
5.42%5.08B
0.42%6.51B
2.77%23.8B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
8.1B
0.34%8.17B
26.68%30.98B
25.12%8.14B
2.76%24.45B
7.1B
15.77%5.77B
5.42%5.08B
0.42%6.51B
2.77%23.8B
Gross dividend payment
Basic earnings per share
102.19
0.35%103.1
26.65%390.86
25.03%102.74
2.71%308.61
89.54
15.67%72.8
5.37%64.095
0.41%82.175
2.77%300.48
Diluted earnings per share
102.19
0.35%103.1
26.65%390.86
25.03%102.74
2.71%308.61
89.54
15.68%72.8
5.35%64.0821
0.41%82.175
2.77%300.48
Dividend per share
0
0
16.67%70
0
20.00%60
30
0
41.18%30
0
25.00%50
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Feb 28, 2026(Q1)Aug 31, 2025(FY)May 31, 2025(Q1)Aug 31, 2024(FY)May 31, 2024(Q4)May 31, 2024(Q3)Feb 29, 2024(Q2)Nov 30, 2023(Q1)Aug 31, 2023(FY)May 31, 2023
Total revenue 273.21B4.03%272.39B4.81%1.01T8.35%261.84B16.59%964.99B249.68B18.09%238.88B18.64%234.78B17.24%241.65B9.57%827.7B
Cost of revenue 216.15B3.83%215.22B2.76%798.11B6.49%207.28B17.86%776.68B201.04B19.21%192.15B20.31%188.86B18.81%194.64B9.11%658.98B
Gross profit 57.06B4.79%57.17B13.26%213.28B16.06%54.56B11.61%188.31B48.64B13.72%46.73B12.21%45.92B11.16%47.01B11.40%168.72B
Operating expense 45.71B5.93%45.53B10.25%172.88B13.05%42.98B13.14%156.8B40.88B13.16%38.83B13.47%39.07B13.86%38.02B13.92%138.59B
Operating profit 11.35B0.56%11.65B28.26%40.4B28.80%11.58B4.55%31.5B7.76B16.53%7.9B5.55%6.85B1.02%8.99B1.12%30.13B
Net non-operating interest income (expenses) -91M-118.42%-83M-274.55%-206M-375.00%-38M-1,275.00%-55M-35M-700.00%-6M-700.00%-6M-700.00%-8M-4M
Non-operating interest income --16M145.45%27M9.09%48M10.00%11M-6.38%44M--11M0.00%12M-8.33%11M-9.09%10M-9.62%47M
Non-operating interest expense --107M124.49%110M156.57%254M172.22%49M94.12%99M--46M63.64%18M54.55%17M50.00%18M-1.92%51M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges) 28M56.00%-99M-35.75%-786M-268.85%-225M-86.17%-579M-609M723.08%162M21.11%-71M-41.86%-61M-266.31%-311M
Less:Restructuring and mergern&acquisition ---15M--0-55.07%31M-25.93%20M-63.49%69M--51M-311.11%-19M-58.33%10M80.00%27M20.38%189M
Less:Other special charges ---13M-51.71%99M3,120.00%755M502.94%205M-120.49%-25M--23M-941.18%-143M-7.58%61M21.43%34M135.47%122M
Less:Write off ------------------535M------------------0
Other non-operating income (expenses) 676M-16.78%625M3.75%2.96B5.03%751M-3.61%2.85B659M-5.35%672M2.28%807M-1.52%715M-3.46%2.96B
Income before tax 11.96B0.18%12.09B25.66%42.37B25.22%12.07B2.89%33.72B7.78B16.89%8.73B5.49%7.58B0.57%9.64B-0.83%32.77B
Income tax 3.86B-0.15%3.92B22.97%11.39B25.38%3.92B3.23%9.27B681M19.17%2.96B5.54%2.5B0.94%3.13B-9.27%8.98B
Net income 8.1B0.34%8.17B26.68%30.98B25.12%8.14B2.76%24.45B7.1B15.77%5.77B5.42%5.08B0.42%6.51B2.77%23.8B
Net income continuous operations --8.1B0.34%8.17B26.68%30.98B25.14%8.14B2.76%24.45B--7.1B15.75%5.77B5.46%5.08B0.40%6.51B2.77%23.8B
Noncontrolling interests
Net income attributable to the company 8.1B0.34%8.17B26.68%30.98B25.12%8.14B2.76%24.45B7.1B15.77%5.77B5.42%5.08B0.42%6.51B2.77%23.8B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 8.1B0.34%8.17B26.68%30.98B25.12%8.14B2.76%24.45B7.1B15.77%5.77B5.42%5.08B0.42%6.51B2.77%23.8B
Gross dividend payment
Basic earnings per share 102.190.35%103.126.65%390.8625.03%102.742.71%308.6189.5415.67%72.85.37%64.0950.41%82.1752.77%300.48
Diluted earnings per share 102.190.35%103.126.65%390.8625.03%102.742.71%308.6189.5415.68%72.85.35%64.08210.41%82.1752.77%300.48
Dividend per share 0016.67%70020.00%6030041.18%30025.00%50
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached Show More